FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2162223132> ?p ?o ?g. }

• W2162223132 endingPage "3454" @default.
• W2162223132 startingPage "3443" @default.
• W2162223132 abstract "Abstract Purpose: To determine the recurring DNA copy number alterations (CNA) in classical Hodgkin lymphoma (HL) by microarray-based comparative genomic hybridization (aCGH) using laser capture microdissected CD30+ Hodgkin and Reed–Sternberg (HRS) cells. Experimental Design: Archived tissues from 27 CD30+ HL plus control samples were analyzed by DNA microarrays. The HL molecular karyotypes were compared with the genomic profiles of germinal center B cells and treatment outcome (chemotherapy responsive vs. primary refractory disease). Results: Gains and losses observed in more than 35% of HL samples were localized to 22 and 12 chromosomal regions, respectively. Frequent gains (&gt;65%) were associated with growth and proliferation, NF-κB activation, cell-cycle control, apoptosis, and immune and lymphoid development. Frequent losses (&gt;40%) observed encompassed tumor suppressor genes (SPRY1, NELL1, and ID4, inhibitor of DNA binding 4), transcriptional repressors (TXNIP, thioredoxin interacting protein), SKP2 (S-phase kinase-associated protein 2; ubiquitin ligase component), and an antagonist of NF-κB activation (PPARGC1A). In comparison to the germinal center profiles, the most frequent imbalances in HL were losses in 5p13 (AMACR, GDNF, and SKP2), and gains in 7q36 (SHH, sonic hedgehog homolog) and 9q34 (ABL1, CDK9, LCN2, and PTGES). Gains (&gt;35%) in the HL chemoresponsive patients housed genes known to regulate T-cell trafficking or NF-κB activation (CCL22, CX3CL1, CCL17, DOK4, and IL10), whereas the refractory samples showed frequent loss of 4q27 (interleukin; IL21/IL2) and 17p12, and gain of 19q13.3 (BCL3/RELB). Conclusion: We identified nonrandom CNAs in the molecular karyotypes of classical HL. Several recurring genetic lesions correlated with disease outcome. These findings may be useful prognostic markers in the counseling and management of patients and for the development of novel therapeutic approaches in primary refractory HL. Clin Cancer Res; 17(10); 3443–54. ©2011 AACR." @default.
• W2162223132 created "2016-06-24" @default.
• W2162223132 creator A5003640697 @default.
• W2162223132 creator A5011783428 @default.
• W2162223132 creator A5023734653 @default.
• W2162223132 creator A5034375294 @default.
• W2162223132 creator A5037972294 @default.
• W2162223132 creator A5039374832 @default.
• W2162223132 creator A5058345454 @default.
• W2162223132 creator A5062213825 @default.
• W2162223132 creator A5086123605 @default.
• W2162223132 date "2011-05-15" @default.
• W2162223132 modified "2023-10-04" @default.
• W2162223132 title "Molecular Karyotypes of Hodgkin and Reed–Sternberg Cells at Disease Onset Reveal Distinct Copy Number Alterations in Chemosensitive versus Refractory Hodgkin Lymphoma" @default.
• W2162223132 cites W1661441964 @default.
• W2162223132 cites W1970516837 @default.
• W2162223132 cites W1972716007 @default.
• W2162223132 cites W1972725743 @default.
• W2162223132 cites W1990453734 @default.
• W2162223132 cites W1999104287 @default.
• W2162223132 cites W2005874024 @default.
• W2162223132 cites W2016658377 @default.
• W2162223132 cites W2026336857 @default.
• W2162223132 cites W2031889549 @default.
• W2162223132 cites W2034400622 @default.
• W2162223132 cites W2048408307 @default.
• W2162223132 cites W2050402493 @default.
• W2162223132 cites W2054357354 @default.
• W2162223132 cites W2054782539 @default.
• W2162223132 cites W2055907134 @default.
• W2162223132 cites W2071582678 @default.
• W2162223132 cites W2071628605 @default.
• W2162223132 cites W2076128933 @default.
• W2162223132 cites W2076477779 @default.
• W2162223132 cites W2077385543 @default.
• W2162223132 cites W2078657089 @default.
• W2162223132 cites W2084241456 @default.
• W2162223132 cites W2094112735 @default.
• W2162223132 cites W2097583243 @default.
• W2162223132 cites W2101154044 @default.
• W2162223132 cites W2102628825 @default.
• W2162223132 cites W2104124301 @default.
• W2162223132 cites W2105165091 @default.
• W2162223132 cites W2119909954 @default.
• W2162223132 cites W2121026884 @default.
• W2162223132 cites W2123978931 @default.
• W2162223132 cites W2132786907 @default.
• W2162223132 cites W2143263914 @default.
• W2162223132 cites W2145608226 @default.
• W2162223132 cites W2146002460 @default.
• W2162223132 cites W2148226187 @default.
• W2162223132 cites W2150123178 @default.
• W2162223132 cites W2154907045 @default.
• W2162223132 cites W2158218476 @default.
• W2162223132 cites W2159476762 @default.
• W2162223132 cites W2161132784 @default.
• W2162223132 cites W2166675034 @default.
• W2162223132 cites W2166766006 @default.
• W2162223132 cites W2170522882 @default.
• W2162223132 cites W2328676772 @default.
• W2162223132 cites W4321429134 @default.
• W2162223132 doi "https://doi.org/10.1158/1078-0432.ccr-10-1071" @default.
• W2162223132 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3096736" @default.
• W2162223132 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21385932" @default.
• W2162223132 hasPublicationYear "2011" @default.
• W2162223132 type Work @default.
• W2162223132 sameAs 2162223132 @default.
• W2162223132 citedByCount "40" @default.
• W2162223132 countsByYear W21622231322012 @default.
• W2162223132 countsByYear W21622231322013 @default.
• W2162223132 countsByYear W21622231322014 @default.
• W2162223132 countsByYear W21622231322015 @default.
• W2162223132 countsByYear W21622231322016 @default.
• W2162223132 countsByYear W21622231322017 @default.
• W2162223132 countsByYear W21622231322018 @default.
• W2162223132 countsByYear W21622231322019 @default.
• W2162223132 countsByYear W21622231322020 @default.
• W2162223132 countsByYear W21622231322021 @default.
• W2162223132 countsByYear W21622231322022 @default.
• W2162223132 countsByYear W21622231322023 @default.
• W2162223132 crossrefType "journal-article" @default.
• W2162223132 hasAuthorship W2162223132A5003640697 @default.
• W2162223132 hasAuthorship W2162223132A5011783428 @default.
• W2162223132 hasAuthorship W2162223132A5023734653 @default.
• W2162223132 hasAuthorship W2162223132A5034375294 @default.
• W2162223132 hasAuthorship W2162223132A5037972294 @default.
• W2162223132 hasAuthorship W2162223132A5039374832 @default.
• W2162223132 hasAuthorship W2162223132A5058345454 @default.
• W2162223132 hasAuthorship W2162223132A5062213825 @default.
• W2162223132 hasAuthorship W2162223132A5086123605 @default.
• W2162223132 hasBestOaLocation W21622231321 @default.
• W2162223132 hasConcept C153911025 @default.
• W2162223132 hasConcept C159654299 @default.
• W2162223132 hasConcept C203014093 @default.
• W2162223132 hasConcept C2777537477 @default.
• W2162223132 hasConcept C2778453870 @default.
• W2162223132 hasConcept C2779338263 @default.
• W2162223132 hasConcept C2779390272 @default.

• next